Psychedelics Law

Policy and Advocacy

At Feldman Legal Advisors, we are at the forefront of shaping the legal and regulatory frameworks that govern access to psychedelics, medical cannabis, adult-use cannabis, and hemp. Our commitment to social justice, equity and responsibility sets us apart as true leaders in this evolving field. We understand that effective advocacy and legislation have the power to create transformative change, and we have a proven track record of doing just that.

As a lead drafter of Denver’s Psilocybin Decriminalization Initiative—the nation's first successful voter-initiated psychedelic policy reform—Partner Courtney Barnes exemplifies our dedication to advancing meaningful change. This groundbreaking initiative is just one example of how we leverage our deep expertise to influence policy at the highest levels. 

Our team is unwavering in its commitment to developing evidence-based policies that champion social equity, justice and responsibility. Whether we are advocating for legislative reform, advising policymakers, or supporting advocacy groups, our mission is to create a more equitable and sustainable legal landscape for all. We believe that the law should not only regulate but also empower and uplift communities, and we are proud to be driving this change forward.

Colorado

At Feldman Legal Advisors, we are dedicated to guiding individuals and organizations through the evolving legal landscape of psychedelic compounds in Colorado. The passage of the Natural Medicine Health Act (NMHA) in 2022 marked a transformative shift in how natural medicines like psilocybin, psilocin, mescaline, ibogaine, and DMT are regulated. For adults aged 21 and older, this groundbreaking legislation not only decriminalized the possession of these substances but also introduced a therapeutic access model that is poised to redefine mental health and wellness practices.

With a deep understanding of psychedelic policy reform, our team is uniquely positioned to offer comprehensive legal support to service providers, facilitators, and other key stakeholders. Our involvement in drafting Denver’s Psilocybin Decriminalization Initiative and other Colorado policy reform initiatives underscores our intimate knowledge of the complex regulatory frameworks that now govern psychedelics in Colorado.

Navigating the licensing requirements under Colorado’s new psychedelic laws can be daunting. Whether you’re seeking a Healing Center, Cultivation Facility, Products Manufacturer, Testing Facility, or Facilitator license, Feldman Legal Advisors is here to ensure you meet every regulatory requirement with confidence. We provide tailored guidance for professionals helping them secure the necessary licensure under the NMHA. Additionally, we offer specialized assistance for out-of-state practitioners looking to transition their practices to Colorado, ensuring they can operate seamlessly under the state's unique regulatory environment. 

Novel Compounds

At Feldman Legal Advisors, we are at the forefront of the transformative wave that psychedelic compounds are bringing to mental health treatment. The journey to develop novel psychedelic compounds is a complex and rigorous process, meticulously guided by the FDA and DEA. This path encompasses organizing sponsors, conducting exhaustive investigations, and navigating multiple phases of clinical trials before achieving final approval. It's a long road, but one filled with immense potential for groundbreaking therapies.

Understanding the intricate landscape of this emerging field, our seasoned attorneys offer unparalleled legal counsel to entrepreneurs, researchers, and investors eager to unlock the therapeutic potential of psychedelic substances. We specialize in crafting strategic solutions that not only foster innovation but also ensure stringent legal compliance and effective risk mitigation.

By partnering with Feldman Legal Advisors, you gain a dedicated ally committed to navigating the multifaceted regulatory environment of psychedelic compound development. We stand ready to support your visionary endeavors, guiding you through each phase of the FDA approval process with expertise and precision.

Embark on this pioneering journey with confidence. Contact us today to discover how we can assist you in bringing revolutionary mental health treatments to fruition while safeguarding your interests every step of the way.